Strengthening US Response to Resistant Gonorrhea (SURRG)

ICR 202106-0920-018

OMB: 0920-1242

Federal Form Document

Forms and Documents
Document
Name
Status
Supplementary Document
2021-08-16
Supplementary Document
2021-08-16
Justification for No Material/Nonsubstantive Change
2021-08-16
Supplementary Document
2021-08-16
Supplementary Document
2021-08-16
Supporting Statement A
2021-08-16
Supporting Statement B
2021-08-16
ICR Details
0920-1242 202106-0920-018
Received in OIRA 201807-0920-007
HHS/CDC 0920-17BAN
Strengthening US Response to Resistant Gonorrhea (SURRG)
Revision of a currently approved collection   No
Regular 08/17/2021
  Requested Previously Approved
36 Months From Approved 09/30/2021
6,820 7,605
2,665 2,976
105,802 109,751

The purpose of this data collection is to guide national recommendations and programmatic responses to antibiotic resistant Neisseria gonorrhoeae. These data will be used by public health officials at the national, state, and local levels to monitor trends in antimicrobial resistant gonorrhea, investigate epidemiologic aspects of gonorrhea, evaluate the effectiveness of strategies employed to slow or stop the spread of resistant gonorrhea, and identify new opportunities for public health interventions.

US Code: 42 USC 241 Name of Law: PHSA
  
None

Not associated with rulemaking

  85 FR 61750 09/30/2020
86 FR 36556 07/12/2021
Yes

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 6,820 7,605 0 -785 0 0
Annual Time Burden (Hours) 2,665 2,976 0 -311 0 0
Annual Cost Burden (Dollars) 105,802 109,751 0 -3,949 0 0
Yes
Miscellaneous Actions
Yes
Miscellaneous Actions
The purpose of SURRG is to improve national capacity to detect, monitor, and respond to emerging antibiotic-resistant gonorrhea. The goals of this activity are to inform a more comprehensive understanding of trends and determinants of drug-resistant gonorrhea, monitor for the emergence of resistance, provide a robust evidence base for directing public health action, pilot novel prevention and control approaches, and evaluate the effectiveness of resistant gonorrhea novel prevention and control approaches. This request is for approval of 2,665 burden hours.

$5,491,383
No
    No
    No
No
No
No
No
Odion Clunis 770 488-0045 lta2@cdc.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
08/17/2021


© 2024 OMB.report | Privacy Policy